iRhythm Technologies, Inc. (IRTC) EPS Estimated At $-0.44

October 14, 2018 - By Dolores Ford

Analysts expect iRhythm Technologies, Inc. (NASDAQ:IRTC) to report $-0.44 EPS on November, 7.They anticipate $0.15 EPS change or 51.72 % from last quarter’s $-0.29 EPS. After having $-0.51 EPS previously, iRhythm Technologies, Inc.’s analysts see -13.73 % EPS growth. The stock increased 5.61% or $4.6 during the last trading session, reaching $86.64. About 346,220 shares traded or 14.36% up from the average. iRhythm Technologies, Inc. (NASDAQ:IRTC) has risen 81.91% since October 14, 2017 and is uptrending. It has outperformed by 66.29% the S&P500.

iRhythm Technologies, Inc., a digital healthcare company, focuses on the provision of ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias in the United States. The company has market cap of $2.08 billion. It offers ZIO Service, a platform that provides wearable biosensor with cloud data analytics that distill data from heartbeats into clinically actionable information. It currently has negative earnings.

More news for iRhythm Technologies, Inc. (NASDAQ:IRTC) were recently published by: Nasdaq.com, which released: “iRhythm Technologies to Report Third Quarter Financial Results on October 30, 2018” on October 09, 2018. Fool.com‘s article titled: “3 Growth Stocks for in-the-Know Investors” and published on September 28, 2018 is yet another important article.

iRhythm Technologies, Inc. (NASDAQ:IRTC) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>